Professor Silke Gillessen is a Medical Oncologist with focus on genitourinary cancer. Since 2020, she is the director of the IOSI (Oncology Institute of Southern Switzerland) and Head of Department of Medical Oncology and still works part time as a Senior Consultant in the Department of Oncology and Haematology at the Kantonsspital St. Gallen in Switzerland, where she had worked almost 20 years. Prof Gillessen completed her specialist training in Medical Oncology at the University Hospital of Basel and the Cantonal Hospital St. Gallen in Switzerland. From 1997 – 2000, she was a clinical research fellow at the Dana Farber Cancer Institute, Harvard Medical School in Boston, USA. After returning to Switzerland, Prof. Gillessen built up the medical oncology unit for genitourinary cancer in the Cantonal Hospital St. Gallen and served for two terms as president of the SAKK GU group. She then chaired the EORTC Genito Urinary Cancers Group. Together with Dr. Omlin she initiated the Advanced Prostate Cancer Consensus Conference, which was held first in March 2015 and again in 2017 and 2019.

Thomas Cerny is Prof. med. for Medical Oncology at the University of Bern, Switzerland. From 1998 to 2017, he served as Chief of the Department of Oncology-Haematology at the Kantonsspital St. Gallen. Prof. Cerny received his medical training in Switzerland (Inselspital, University Hospital of Bern) and the United Kingdom (Christie Hospital and Patterson Institute, Manchester). His research focuses on clinical pharma-oncology, especially developing and exploring new drugs and improving therapies for patients with rare cancers such as sarcomas. Prof. Cerny has decades of experience conducting and participating in national and international clinical studies for patients with lung cancer, malignant lymphoma, and many other types of malignancies. He has more than 250 peer-reviewed publications.

Additionally, Prof. Cerny is a national leader in the political aspects of improving patient care, quality of life, and equal access to diagnostic and therapeutic progress in oncology. He is a former president of Oncosuisse, which houses the federal National Strategy against Cancer (NSK), and of the Swiss Cancer League (KLS), which leads this project. Prof. Cerny also is acting president of the best-known foundation in Cancer Research in Switzerland (KFS) and serves on the board of the Human Medicine Expert Committee (HMEC) of Swissmedic.

Dr. Aurelius Omlin is a Medical Oncologist at Kantonsspital St. Gallen in Switzerland who focuses on genitourinary cancer and early-phase clinical trials. Dr. Omlin performed his specialist training in Medical Oncology at the University Hospital of Berne, the regional hospital in Thun and the Cantonal Hospital St. Gallen in Switzerland. From 2010 – 2013 he was a clinical research fellow at the Royal Marsden NHS Foundation Trust and the Institute of Cancer Research (ICR) in London under Prof Johann de Bono focusing on early clinical trials especially for men with advanced prostate cancer. After his return to Switzerland, Dr. Omlin together with Prof Silke Gillessen initiated the Advanced Prostate Cancer Consensus Conference, which was first held in March 2015 and then again in 2017 and 2019.

Dr. Ruth Lyner is a lawyer working as a designer and distributor for sports fashion since 25 years. She founded her own company together with her husband who was diagnosed with prostate cancer. For APC, Ruth Lyner represents patients and their family members.